Stockscreener 앱 받기
131.69
0.69%
0.90
시간 외 거래:
131.69
Insulet Corp 주식(PODD)의 최신 뉴스
Insulet Corporation (PODD) Stock Forecasts - Yahoo Finance
Important Notice to Long-Term Shareholders of Beta Bionics, - GlobeNewswire
A tubeless insulin pump maker will report results before markets open Nov. 4. - Stock Titan
What Is Changing for Insulet (NASDAQ:PODD)? - Kalkine Media
Insulet Corporation (PODD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch
Insulet Corp. stock underperforms Monday when compared to competitors - MarketWatch
38 life sciences companies land $40M in tax incentives for 1,644 Mass. jobs - The Business Journals
Why is Insulet stock sliding today? - Investing.com
Insulet Sees Emerging Headwinds From New Market Entrants in 2027, 2028, Oppenheimer Says - marketscreener.com
Insulet Corp Lobbyists, 2025 - OpenSecrets
Insulet (PODD) Stock May Trade At A Discount To Fair Value - Yahoo Finance
PODD5061895 Bond Profile: Coupon and Redemption - TradingView
Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum - Yahoo Finance
Transcript : Insulet Corporation Presents at Bernstein Insights - marketscreener.com
Insulet at Bernstein healthcare forum: growth, retention and new AID push - Investing.com
How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks? - Barchart.com
Insulet (PODD) Refinances $475 Million Term Loans and Expands Re - gurufocus.com
Insulet Reprices $475 Million Term Loans, Expands Revolver to $750 Million in Credit Amendment - TradingView
Insulet (PODD) cuts interest margins on $475M loan and expands credit access - Stock Titan
Insulet Corporation Amends And Increases Credit Agreement, Refinances $475 Million Term Loans, And Expands Revolving Credit Facility To $750 Million - marketscreener.com
Insulet stock gains as Bank of America stake and guidance highlight upside potential - AD HOC NEWS
Insulet Corporation(NasdaqGS: PODD) dropped from FTSE All-World Index - marketscreener.com
Insulet stock heads into the open after a modest September 18, 2026 gain - AD HOC NEWS
Insulet stock gains support from Bank of America stake and strong Q1 2026 figures - AD HOC NEWS
Insulet Stock Price Forecast. Should You Buy PODD? - StockInvest.us
The maker of Omnipod will speak at a healthcare forum Sept. 24 - Stock Titan
Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum - Yahoo Finance
The largest med-device firms in Mass. collectively increased revenue in 2025 - The Business Journals
Insulet Corporation (PODD) Adopts Nonqualified Deferred Compensa - GuruFocus
BCSM Exits Insulet Corporation (PODD), Maintains Watchlist Status - Yahoo Finance
Insulet stock heads into the open after a modest decline - AD HOC NEWS
Insulet Faces Class Action Lawsuit Over Product Safety Issues - Intellectia AI
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Important Notice to Long-Term Shareholders of FuelCell - GlobeNewswire
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
Insulet Weighs Major Acton Expansion as State Offers $40M in Incentives - Boston Real Estate Times
Grabar Law probes Bloom Energy, Cogent, Insulet, Primoris for fiduciary breaches - scanx.trade
Insulet Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Insulet Corp (PODD) Shares Fall 3.1% -- What GF Score of 77 Tells Investors - GuruFocus
Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Insulet at Wells Fargo conference: guidance cut meets long-term optimism - investing.com
Is Insulet Corp (PODD) a Bargain After 3.5% Drop? GF Value Says Undervalued - GuruFocus
Insulet Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Why Insulet (PODD) Stock Is Down Today - Quiver Quantitative
State offers record $40M package to keep medical device company in Mass. - NBC Boston
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now? - Yahoo Finance
Artisan Sold Insulet (PODD) Due to Competition Concerns - Yahoo Finance
Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report? - Yahoo Finance
Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks - Yahoo Finance
Insulet (PODD) Stock May Be 40% Undervalued On Fair Value Grounds - Yahoo Finance
Is Insulet (PODD) Undervalued On Lawsuit And Device Correction Risks? - Yahoo Finance
Important Notice to Long-Term Shareholders of Hub Group, - GlobeNewswire
Insulet crushed its most recent earnings, but the market's focus on its slightly lowered outlook has presented a buying opportunity - CNBC
PODD CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 - TMX Newsfile
Insulet Corporation: Strong Growth Meets A New Execution Problem (NASDAQ:PODD) - Seeking Alpha
PODD DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Insulet Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 31 Deadline in Securities Class ActionPODD - TMX Newsfile
MONDAY PODD INVESTOR DEADLINE: Insulet Corporation - GlobeNewswire
0.26%
0.38%
자본화:
|
볼륨(24시간):